guest column How a shifting business model in Houston can keep health tech attractive to investors Kelly ReddingPeter Micca
fresh funding Houston biotech startup secures $10M seed round to propel cancer-fighting therapy from bench to bedside
money moves Houston firm scores 2 grants to support testing treatment for addiction, neurodegenerative diseases
